ENDRA Life Sciences Inc. – NASDAQ:NDRA

ENDRA Life Sciences stock price today

$4.55
-1.75
-27.78%
Financial Health
0
1
2
3
4
5
6
7
8
9

ENDRA Life Sciences stock price monthly change

+6792.78%
month

ENDRA Life Sciences stock price quarterly change

+6792.78%
quarter

ENDRA Life Sciences stock price yearly change

+218.18%
year

ENDRA Life Sciences key metrics

Market Cap
2.87M
Enterprise value
N/A
P/E
-0.56
EV/Sales
N/A
EV/EBITDA
0.33
Price/Sales
N/A
Price/Book
N/A
PEG ratio
-0.03
EPS
-1.23
Revenue
N/A
EBITDA
-10.10M
Income
-9.89M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

ENDRA Life Sciences stock price history

ENDRA Life Sciences stock forecast

ENDRA Life Sciences financial statements

ENDRA Life Sciences Inc. (NASDAQ:NDRA): Profit margin
Jun 2023 0 -2.55M
Sep 2023 0 -3.10M
Dec 2023 428.40K -1.45M -340.69%
Mar 2024 0 -2.77M
ENDRA Life Sciences Inc. (NASDAQ:NDRA): Analyst Estimates
Dec 2023 428.40K -1.45M -340.69%
Mar 2024 0 -2.77M
Oct 2025 100K -432.18K -432.19%
Dec 2025 500K -432.18K -86.44%
  • Analysts Price target

  • Financials & Ratios estimates

0%
Yield TTM
ENDRA Life Sciences Inc. (NASDAQ:NDRA): Payout ratio
Payout ratio 0%
ENDRA Life Sciences Inc. (NASDAQ:NDRA): Dividend Yield
2019 0.02%
2020 0%
2021 0%
2022
2023
ENDRA Life Sciences Inc. (NASDAQ:NDRA): Debt to assets
Jun 2023 9244776 2.31M 25.03%
Sep 2023 7602917 2.40M 31.65%
Dec 2023 6754146 1.09M 16.21%
Mar 2024 5060701 1.36M 26.92%
ENDRA Life Sciences Inc. (NASDAQ:NDRA): Cash Flow
Jun 2023 -2.26M 0 4.73M
Sep 2023 -2.59M 0 1.11M
Dec 2023 -2.17M 2.27K 1.67M
Mar 2024 -2.14M -23.79K 468.90K

ENDRA Life Sciences alternative data

ENDRA Life Sciences Inc. (NASDAQ:NDRA): Employee count
Aug 2023 21
Sep 2023 21
Oct 2023 21
Nov 2023 21
Dec 2023 21
Jan 2024 21
Feb 2024 21
Mar 2024 21
Apr 2024 21
May 2024 21
Jun 2024 21
Jul 2024 21

ENDRA Life Sciences other data

2.80% -5.23%
of NDRA is owned by hedge funds
60.23K -112.62K
shares is hold by hedge funds

ENDRA Life Sciences Inc. (NASDAQ:NDRA): Insider trades (number of shares)
Period Buy Sel
Aug 2022 40000 0
Nov 2022 10000 0
Dec 2022 1500 0
May 2023 140000 0
Transaction Date Insider Security Shares Price per share Total value Source
Purchase
THORNTON MICHAEL MILOS officer: Chief Te.. Common Stock 15,000 $1.65 $24,750
Purchase
DIGIANDOMENICO ANTHONY director
Common Stock 83,333 $1.2 $100,000
Purchase
DIGIANDOMENICO ANTHONY director
Warrants 41,667 $1.4 $58,334
Purchase
THORNTON MICHAEL MILOS officer: Chief Te.. Common Stock 1,500 $3.4 $5,100
Purchase
TOKMAN ALEXANDER Y director
Common Stock 10,000 $0.17 $1,700
Purchase
THORNTON MICHAEL MILOS officer: Chief Te.. Common Stock 20,000 $0.27 $5,400
Purchase
TOKMAN ALEXANDER Y director
Common Stock 20,000 $0.26 $5,200
Purchase
THORNTON MICHAEL MILOS officer: Chief Te.. Common Stock 25,000 $0.21 $5,250
Purchase
THORNTON MICHAEL MILOS officer: Chief Te.. Common Stock 25,000 $0.22 $5,500
Purchase
MICHELON FRANCOIS ROGER director, officer.. Common Stock 5,100 $0.19 $969
Patent
Grant
Filling date: 24 Feb 2022 Issue date: 2 Aug 2022
Grant
Filling date: 25 Mar 2022 Issue date: 19 Jul 2022
Grant
Filling date: 25 Mar 2022 Issue date: 5 Jul 2022
Grant
Filling date: 17 Dec 2021 Issue date: 28 Jun 2022
Grant
Filling date: 12 Feb 2020 Issue date: 24 May 2022
Grant
Filling date: 18 Oct 2021 Issue date: 26 Apr 2022
Grant
Filling date: 7 Nov 2018 Issue date: 19 Apr 2022
Grant
Filling date: 1 Oct 2019 Issue date: 8 Mar 2022
Application
Filling date: 21 May 2021 Issue date: 2 Dec 2021
Grant
Filling date: 21 May 2021 Issue date: 16 Nov 2021
Friday, 22 November 2024
businesswire.com
Friday, 15 November 2024
businesswire.com
Wednesday, 6 November 2024
businesswire.com
Friday, 30 August 2024
benzinga.com
Thursday, 22 August 2024
seekingalpha.com
Wednesday, 7 August 2024
businesswire.com
Monday, 17 June 2024
investorplace.com
Tuesday, 4 June 2024
businesswire.com
businesswire.com
Monday, 20 May 2024
businesswire.com
Tuesday, 14 May 2024
Seeking Alpha
Thursday, 28 March 2024
Seeking Alpha
Tuesday, 14 November 2023
Seeking Alpha
Tuesday, 7 November 2023
Business Wire
Monday, 14 August 2023
Seeking Alpha
Monday, 15 May 2023
Seeking Alpha
Friday, 28 April 2023
InvestorPlace
Tuesday, 14 March 2023
Seeking Alpha
Tuesday, 7 March 2023
Business Wire
Monday, 14 November 2022
Seeking Alpha
Monday, 15 August 2022
Seeking Alpha
Tuesday, 17 May 2022
PennyStocks
Thursday, 12 May 2022
Seeking Alpha
Friday, 8 April 2022
PennyStocks
Wednesday, 30 March 2022
Seeking Alpha
Wednesday, 9 March 2022
Business Wire
Wednesday, 5 January 2022
Business Wire
Thursday, 30 December 2021
Zacks Investment Research
Monday, 15 November 2021
Seeking Alpha
Zacks Investment Research
  • What's the price of ENDRA Life Sciences stock today?

    One share of ENDRA Life Sciences stock can currently be purchased for approximately $4.55.

  • When is ENDRA Life Sciences's next earnings date?

    Unfortunately, ENDRA Life Sciences's (NDRA) next earnings date is currently unknown.

  • Does ENDRA Life Sciences pay dividends?

    No, ENDRA Life Sciences does not pay dividends.

  • How much money does ENDRA Life Sciences make?

    ENDRA Life Sciences has a market capitalization of 2.87M.

  • What is ENDRA Life Sciences's stock symbol?

    ENDRA Life Sciences Inc. is traded on the NASDAQ under the ticker symbol "NDRA".

  • What is ENDRA Life Sciences's primary industry?

    Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.

  • How do i buy shares of ENDRA Life Sciences?

    Shares of ENDRA Life Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are ENDRA Life Sciences's key executives?

    ENDRA Life Sciences's management team includes the following people:

    • Mr. Francois Michelon Chairman, Pres & Chief Executive Officer(age: 59, pay: $511,340)
    • Mr. Michael Thornton Chief Technology Officer(age: 57, pay: $363,770)
  • How many employees does ENDRA Life Sciences have?

    As Jul 2024, ENDRA Life Sciences employs 21 workers.

  • When ENDRA Life Sciences went public?

    ENDRA Life Sciences Inc. is publicly traded company for more then 8 years since IPO on 30 Jun 2017.

  • What is ENDRA Life Sciences's official website?

    The official website for ENDRA Life Sciences is endrainc.com.

  • Where are ENDRA Life Sciences's headquarters?

    ENDRA Life Sciences is headquartered at 3600 Green Court, Ann Arbor, MI.

  • How can i contact ENDRA Life Sciences?

    ENDRA Life Sciences's mailing address is 3600 Green Court, Ann Arbor, MI and company can be reached via phone at +7 343350468.

ENDRA Life Sciences company profile:

ENDRA Life Sciences Inc.

endrainc.com
Exchange:

NASDAQ

Full time employees:

21

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

ENDRA Life Sciences Inc. develops technology for improving the capabilities of clinical diagnostic ultrasound. The company develops thermo-acoustic enhanced ultrasound technology that transmits sound waves, which bounce off tissues, organs, and blood in the body for use in the treatment of nonalcoholic fatty liver disease, as well as in temperature monitoring of thermoablative surgery, vascular imaging, and tissue perfusion. It also offers diagnostic imaging technologies, such as computed tomography, magnetic resonance imaging, and ultrasound that allow physicians to look inside a person's body to guide treatment or gather information about medical conditions, such as broken bones, cancers, signs of heart disease, or internal bleeding. The company has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.

3600 Green Court
Ann Arbor, MI 48105-1570

CIK: 0001681682
ISIN: US29273B3024
CUSIP: 29273B104